Stay updated with breaking news from கியோவா கிரீன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asian Markets Display Mixed Trend CANBERA (dpa-AFX) - Asian stock markets are trading mixed on Wednesday, following the broadly positive cues overnight from Wall Street, as traders picked up stocks at reduced levels after the recent steep drop, even amid concerns about the recent acceleration in the spread of the highly contagious coronavirus delta variant in several parts of the world. The rising tension between China and the West is also denting sentiment. Asian Markets closed mostly lower on Tuesday. The Australian stock market is sharply higher on Wednesday, recouping some of the losses of the previous two sessions, with the benchmark S&P/ASX 200 breaking above the 7,300 level, following the broadly positive cues overnight from Wall Street. Traders are optimistic about domestic economic recovery after the minutes of the RBA s July policy meeting showed that the economic recovery in Australia has been stronger than earlier expected and is forecast to continue. ....
Das Sporttagebuch mit Michael Knöppel - 4. Juli 2021 Kyowa Kirin gibt EU-Zulassung für die Selbstverabreichung von CRYSVITA® ▼ (Burosumab) zur Behandlung der X-chromosomalen Hypophosphatämie (XLH) bekannt 20.07.2021 Kyowa Kirin Co. Ltd. (TSE: 4151, Kyowa Kirin) gab heute bekannt, dass CRYSVITA ® (Burosumab) die EU-Zulassung zur Behandlung der X-chromosomalen Hypophosphatämie (XLH), einer seltenen Knochenstoffwechselerkrankung, an der Kinder und Erwachsene erkranken können, für die Selbstverabreichung erhalten hat. Die Zulassung bedeutet, dass bestimmte Patienten oder Pflegepersonen gegebenenfalls dafür geeignet sind, CRYSVITA auf Empfehlung des behandelnden Arztes selbst zu verabreichen, und zwar bei der zugelassenen Indikation zur Behandlung von XLH bei Kindern und Jugendlichen im Alter von 1 bis 17 Jahren mit röntgenologischem Nachweis einer Knochenerkrankung sowie bei Erwachsenen. ....
El 64% de cuidadores de personas con enfermedades raras son mujeres que ven limitado su desarrollo social, según FEDER europapress.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europapress.es Daily Mail and Mail on Sunday newspapers.
EU approval for self-administered Crysvita pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH) apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.